Abstract
Malaria remains one of the world's most devastating infectious diseases. Drug resistance to all classes of antimalarial agents has now been observed, highlighting the need for new agents that act against novel parasite targets. The complete sequencing of the Plasmodium falciparum genome has allowed the identification of new molecular targets within the parasite that may be amenable to chemotherapeutic intervention. In this review, we investigate four possible targets for the future development of new classes of antimalarial agents. These targets include histone deacetylase, the aspartic proteases or plasmepsins, aminopeptidases and the purine salvage enzyme hypoxanthine-xanthine-guanine phosphoribosyltransferase.
| Original language | English |
|---|---|
| Pages (from-to) | 1087-1098 |
| Number of pages | 12 |
| Journal | Expert Review of Anti-Infective Therapy |
| Volume | 7 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Nov 2009 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aminopeptidase
- Aspartic protease
- Histone deacetylase
- Hypoxanthine-xanthine- guanine phosphoribosyltransferase
- Malaria
- Molecular target
- Plasmepsin
- Plasmodium falciparum
Fingerprint
Dive into the research topics of 'Plasmodium falciparum: New molecular targets with potential for antimalarial drug development'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver